The role of lymphadenectomy in prostate cancer

Nature Clinical Practice Urology

Volumn 2, Issue 7, 2005, Pages 336-342

  Burkhard, Fiona C ^a   Schumacher, Martin ^a   Studer, Urs E ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Disease progression; Extended lymphadenectomy; Lymph node metastasis; Prostate cancer; Standard lymphadenectomy

Indexed keywords

ANTIANDROGEN; BIOLOGICAL MARKER; LOW MOLECULAR WEIGHT HEPARIN; PROSTATE SPECIFIC ANTIGEN;

BLEEDING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; HUMAN; ILIAC VEIN; INTERNAL ILIAC ARTERY; LUNG EMBOLISM; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; LYMPHOCELE; LYMPHOSCINTIGRAPHY; MALE; MEDICAL DECISION MAKING; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; REVIEW; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; VEIN THROMBOSIS;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 23744438131     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0245     Document Type: Review

References (49)

1. Partin AW at al. (2001) Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58: 843-848
2. Mathiesen O et al. (1990) Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol 29: 721-725
3. Siewert JR et al. (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461
4. Friedberg V (1989) Results of 108 exenteration operations in advanced gynecologic cancers. Geburtshilfe Frauenheilkunde 49: 423-427
5. Caplin S et al. (1998) For patients with Duke's B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 83: 666-672
6. Mills RD et al. (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166: 19-23
7. Leissner J et al. (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85: 817-823
8. Wolf JS Jr et al. (1995) The use and accuracy of crosssectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 153: 993-999
9. Pailk ML et al. (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163: 1693-1696
10. Tempany CM and McNeil BJ (2001) Advances in biomedical imaging. JAMA 285: 562-567
11. Wawroschek F et al. (2003) Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70: 303-310
12. Jeschke S et al. (2005) Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 173: 1943-1946
13. Mattei A et al. (2005) Advantages of preoperative imaging with Technetium-99m-nanocolloid for prostate-sentinel-lymph-node-adenectomy: accuracy and surgical detection time using presurgical imaging guidance prior to gamma-probe-detection versus gamma-probe detection alone. J Urol 173: 433
14. Gronau E et al. (2005) Sentinel lymph node resection in prostate cancer patients with a PSA higher than 20ng/ml. J Urol 173: 437
15. Harisinghani MG et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491-2499
16. Stone NN et al. (1997) Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 158: 1891-1894
17. Heidenreich A et al. (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167: 1681-1686
18. Weingärtner K et al. (1996) Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156: 1969-1971
19. Bader P et al. (2002) Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168: 514-518; discussion 518
20. Bluestein DL et al. (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151: 1315-1320
21. Petros JA and Catalona WJ (1992) Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147: 1574-1575
22. Bishoff JT et al. (1995) Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45: 270-274
23. Heidenreich A et al. (2004) Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy (RRP) - an update on > 300 cases. J Urol 171: a312
24. Tenaglia JL and Iannucci M (online March 2004) Extended pelvic lymphadenetomy for the treatment of localized prostate carcinoma. European Urology Today 15: 15 [http://www.uroweb.nl/files/uploaded_files/EUT%202004%20MAR.pdf] (accessed 10 June 2005)
25. Clark T et al. (2003) Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169: 145-147; discussion 147-148
26. Link RE and Morton RA (2001) Indications for pelvic lymphadenectomy in prostate cancer. Urol Clin North Am 28: 491-498
27. Schumacher M et al. (2004) Lymph node metastasis in patients with prostate cancer and with a PSA < 10ng/ml? Eur Urol 2 (Suppl 3): s17
28. Burkhard FC et al. (2005) Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int 95: 275-278
29. Jhaveri FM et al. (1999) Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 54: 884-890
30. Han M et al. (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28: 555-565
31. Bader P et al. (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849-854
32. Roehl KA et al. (2004) Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172: 910-914
33. Steinberg GD et al. (1990) Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144: 1425-1432
34. Frazier HA et al. (1994) Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol 12: 308-312
35. deKernion JB et al. (11990) Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy. J Urol 144: 700-703
36. Zwergel U et al. (2004) Lymph node positive prostate cancer: long-term survival data after radical prostatectomy. J Urol 171: 1128-1131
37. Catalona WJ et al. (1988) Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 140: 540-543
38. Pound CR et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597
39. Golimbu M et al. (11987) Radical prostatectomy for stage D1 prostate cancer. Urology 30: 427-435
40. Aus G et al. (2003) Prognostic factors and survival in node-positive (N1) prostate cancer - a prospective study based on data from a Swedish population-based cohort. Eur Urol 43: 628
41. Cheng L et al. (2001) Risk of prostate carcinoma death in patients with lymph node metastass. Cancer 91: 66-73
42. Bader P et al. (2004) Limited lymph node dissection in prostate cancer may miss lymph node metastasis and determines outcome of apparently pNO prostate cancer. Eur Urol 3: 16
43. Daneshmand S et al. (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172: 2252-2255
44. Allaf ME et al. (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172: 1840-1844
45. Dimarco DS et al. (2005) The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173: 1121-1125
46. Di Blasio CJ et al. (2003) Association between number of lymph nodes removed and freedom from disease progression in patients receiving pelvic lymph node dissection during radical prostatectomy for prostate cancer. J Urol 169: a456
47. Palapattu GS et al. (2004) Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 172: 1860-1864
48. Cadeddu JA et al. (1997) Stage D1 (T1-3, N1-3, MO) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology 50: 251-255
49. Messing E et al. (2003) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer; Results at 10 years of EST 3886. J Urol 169: 396